3M™ Skin and Nasal Antiseptic, 192401, 4 mL, 12 Each/Carton, 4 Carton/Case
About the product
Designed to fit easily into your preoperative protocol, Skin and Nasal Antiseptic features a unique, pH balanced, buffered formulation10 with a film forming polymer that increases persistence and helps reduce the risk of surgical site infections when part of a comprehensive preoperative protocol.
Product details
One time application for preoperative nasal decolonization.
S. aureus is the leading cause of surgical site infections (SSIs), with 80% of infections from S. aureus coming directly from a patient's nasal flora. Fitting seamlessly into your preoperative process, Skin and Nasal Antiseptic uses a simple, one time application that reduces bacteria in the nares by 99.5% in one hour3 and maintains this reduction for at least 12 hours.*1 As part of a comprehensive preoperative protocol, our skin and nasal antiseptic solution is an important tool to help reduce surgical site infections (SSIs) while supporting antibiotic stewardship.2
*As demonstrated through in vitro testing; means values. 13M study 05-011100
- Helps lowers the risk of surgical site infections for your patients with a one time application when used as part of a comprehensive preoperative protocol.2
- Features a film forming, polymer designed not to drip. Does not contain alcohol and has demonstrated excellent acceptability.4
- The broad spectrum, fast acting antiseptic fits easily into your preoperative protocol.1
- Helps improve patient safety and protocol compliance without alcohol or antibiotics. Directly observed application of Skin and Nasal Antiseptic ensures compliance, unlike other methods addressing nasal decolonization.2
- Designed to be administered one hour before surgery to reduce bacteria in the nares.
Suggested Applications
- For preparation of skin prior to surgery
- Helps reduce bacteria that can potential cause skin infections
Legal
1 3M Study 05-011100
2 Phillips M, Rosenberg A, Shopsin B, et al. Preventing surgical site infections: A randomized, open label trial of nasal mupirocin ointment and nasal povidone iodine solution. Infect Control Hosp Epidemiol 2014;35(7):826-832.
3 3M Study 05-010945
4 Solventum data on file
Product specifications
| Catalog number |
Catalog number
192401 |
| Category name |
Category name
Patient Skin Prep |
Subscribe to emails
Join our email list to receive updates on new Solventum products, helpful resources, and educational opportunities. Choose the topics you want to hear more about.
